A good prognostic indicator for resectable colorectal, hepatocellular, and endometrial cancers has been demonstrated to be the inflammation-immunity-nutrition score based on the preoperative hs-CRP, LYM, and ALB composite score (Antonio et al., 2015; Wang et al., 2024). Here, ALB is linked to endometrial cancer.